Nanoparticle Drug Delivery Targets Cancer


Medical researchers at Penn State University have developed a nontoxic nanoparticle they say is an all-around effective delivery system for both therapeutic drugs and the fluorescent dyes that can track their delivery. The calcium phosphate particles, ranging in size from 20 to 50 nanometers, have been shown to successfully enter cells and dissolve harmlessly, releasing their cargo of drugs or dye.

In an article appearing in Nano Letters, an interdisciplinary group of materials scientists, chemists, bioengineers, physicists, and pharmacologists report on the particles, whose primary use is envisioned to be targeted cancer therapies. The ability to deliver numerous drugs that have been shown to inhibit cell growth associated with vascular disease is also intersting, however.

Several drugs have been shown in cultures to be promising for reducing atherosclerosis (hardening of the arteries) and restenosis (the narrowing of blood vessels after balloon angioplasty). The problem has been in delivering any of these drugs to a target, according to Peter Butler, associate professor of bioengineering.

Time Correlated Single Photon Counting

Measuring the activity of particles this size necessitates special techniques. Butler and his students used high speed lasers for measuring the size of fluorescent dye-containing particles from their diffusion in solution.

“We use a technique called time correlated single photon counting. This uses pulses of laser light to read the time, on the order of nanoseconds, that molecules fluoresce.” With this method his group was able to measure the size of the particles and their dispersion in solution, in this case a phosphate-buffered saline that is used as a simple model for blood,”

Butler says.

“What we did in this study was to change the original neutral pH of the solution, which is similar to blood, to a more acidic environment, such as around solid tumors and in the parts of the cell that collect the nanoparticles-containing fluid immediately outside the cell membrane and bring it into the cell. When we lower the pH, the acidic environment dissolves the calcium phosphate particle. We can see that the size of the particles gets very small, essentially down to the size of the free dye that was inside the particles. That gives us evidence that this pH change can be used as a mechanism to release any drug that is encapsulated in the particle,“

Butler explains.

Ceramide Molecules

Ceramide, a chemotherapeutic molecule that initiates cell death in cancer cells, has the ability to slow growth in healthy cells. Mark Kester, professor of pharmacology, and associate professor of pharmacology Jong Yun have optimized ceramide for both cancer and vascular disease.

In an experiment performed by Kesters and Yuns groups in the Penn State Milton S. Hershey Medical Center and Penn State College of Medicine using human vascular smooth muscle cells in vitro, ceramide encapsulated in calcium phosphate nanoparticles reduced growth of muscle cells by up to 80 percent at a dose 25 times lower than ceramide administered freely, without damaging the cells.

The calcium phosphate nanoparticles were developed by Jim Adair, professor of materials science and engineering, and his students. The nanoparticles have several benefits other drug delivery systems do not, according to lead author Thomas Morgan, one of the graduate students in Adairs group.

Unlike quantum dots, which are composed of toxic metals, calcium phosphate is a safe, naturally occurring mineral that already is present in substantial amounts in the bloodstream.

“What distinguishes our method are smaller particles (for uptake into cells), no agglomeration (particles are dispersed evenly in solution), and that we put drugs or dyes inside the particle where they are protected, rather than on the surface. For reasons we dont yet understand, fluorescent dyes encapsulated within our nanoparticles are four times brighter than free dyes,“

Morgan says.

“Drugs and dyes are expensive. but an advantage of encapsulation is that you need much less of them. We can make high concentrations in the lab, and dilute them way down and still be effective. We even believe we can combine drug and dye delivery for simultaneous tracking and treatment. Thats one of the things we are currently working on,”

he adds.

Related Posts:

Last Updated on December 7, 2022